SION Sionna Therapeutics, Inc.

NASDAQ
$3.70

Sionna Therapeutics, Inc. (SION) is expected to report earnings on November 4, 2026, before the market open. The consensus earnings estimate is a loss of $0.63 per share.

Sionna Therapeutics Missed Consensus Estimates
Tuesday, November 10, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Nov 4
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.63)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.76

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sionna Therapeutics, Inc.

Sionna Therapeutics Inc. is a clinical-stage biopharmaceutical company by developing novel medicines that normalize the function of the CFTR protein. Sionna Therapeutics Inc. is based in BOSTON.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.